AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27892822 — intervention group
Group type: EXPERIMENTAL
Intervention: EG1 (+/‐) - text focusing on negative and positive premenstrual changes
Number of subjects: 241
Study 27892822 — intervention group
Group type: COMPARATOR
Intervention: CG - control group text
Number of subjects: 241
Study 27061082 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrubicin and cisplatin (AP)
Number of subjects: 300
Study 27061082 — intervention group
Group type: COMPARATOR
Intervention: Etoposide and cisplatin (EP)
Number of subjects: 300
Study 24270933 — intervention group
Group type: EXPERIMENTAL
Intervention: IV morphine 0.1 mg/kg with promethazine 25 mg
Number of subjects: 59
Study 24270933 — intervention group
Group type: COMPARATOR
Intervention: IV morphine 0.1 mg/kg
Number of subjects: 59
Study 22506833 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraosseous injection with the X‐Tip system
Number of subjects: 40
Study 22506833 — intervention group
Group type: COMPARATOR
Intervention: Periodontal ligament injections (PDL)
Number of subjects: 40
Study 20558628 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated baseline transpulmonary gradient (TPG)
Number of subjects: 501
Study 20558628 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated pulmonary vascular resistance index (PVRi)
Number of subjects: 501
Study 17355300 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation during pregnancy
Number of subjects: 414
Study 16285944 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic human PYY3-36 (0.2, 0.4, and 0.8 pmol.kg(‐1).min(‐1))
Number of subjects: 0
Study 16285944 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic human PYY3-36
Number of subjects: 0
Study 16285944 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic human PYY3-36 (highest dose)
Number of subjects: 0
Study 12087119 — intervention group
Group type: EXPERIMENTAL
Intervention: CD‐ROM‐based multimedia program titled 'Forgetfulness: What's Normal and What's Not'
Number of subjects: 113
Study 12087119 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 113
Study 12087119 — intervention group
Group type: EXPERIMENTAL
Intervention: CD‐ROM‐based multimedia program
Number of subjects: 113
Study 10461281 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Promoting Schools intervention
Number of subjects: 22
Study 8545306 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing interventions to encourage parents to use well-child services
Number of subjects: 2053
Study 8545306 — intervention group
Group type: COMPARATOR
Intervention: Control group (families without phones)
Number of subjects: 2053
Study 2143063 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial floxuridine
Number of subjects: 74
Study 2143063 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fluorouracil
Number of subjects: 74
Study 422100 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzbromarone (50 mg to 100 mg/day)
Number of subjects: 16
Study 31935779 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-activity HIIT (20 minutes during PE classes, 2 times a week for 3 months)
Number of subjects: 46
Study 31935779 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-activity HIIT
Number of subjects: 46
Study 30076087 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 120
Study 30076087 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic
Number of subjects: 120
Study 30076087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 27932595 — intervention group
Group type: EXPERIMENTAL
Intervention: Not regularly cleaning the container used for transporting water for household consumption
Number of subjects: 0
Study 27932595 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in villages with larger concentrations of cattle and having more livestock sharing the same water source as for human consumption
Number of subjects: 0
Study 27932595 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleaning the water container
Number of subjects: 0
Study 25782422 — intervention group
Group type: EXPERIMENTAL
Intervention: D2 (ergocalciferol)
Number of subjects: 33
Study 25782422 — intervention group
Group type: EXPERIMENTAL
Intervention: D3 (cholecalciferol)
Number of subjects: 33
Study 25782422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 23456752 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid meal (bars) with water
Number of subjects: 40
Study 23456752 — intervention group
Group type: COMPARATOR
Intervention: Liquid meal (shakes)
Number of subjects: 40
Study 21874538 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin 4 mg once daily for 12 weeks
Number of subjects: 355
Study 21874538 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 40 mg once daily for 12 weeks
Number of subjects: 355
Study 21874538 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin 4 mg
Number of subjects: 355
Study 21874538 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 40 mg
Number of subjects: 355
Study 19673654 — intervention group
Group type: EXPERIMENTAL
Intervention: Retroperitoneal laparoscopic radical nephrectomy
Number of subjects: 352
Study 19673654 — intervention group
Group type: COMPARATOR
Intervention: Open radical nephrectomy
Number of subjects: 352
Study 16686577 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (JUMP group)
Number of subjects: 30
Study 16686577 — intervention group
Group type: COMPARATOR
Intervention: Physical education program (CONT group)
Number of subjects: 30
Study 15292747 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-year physical education program (curricular materials, staff development, on-site follow-up)
Number of subjects: 25000
Study 15292747 — intervention group
Group type: COMPARATOR
Intervention: Control schools (usual programs)
Number of subjects: 25000
Study 11770034 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration (UF)
Number of subjects: 50
Study 11770034 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study 9006584 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone replacement therapy
Number of subjects: 0
Study 9006584 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone therapy
Number of subjects: 0
Study 8501479 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire
Number of subjects: 150
Study 8501479 — intervention group
Group type: COMPARATOR
Intervention: Interviewer-administered questionnaire
Number of subjects: 150
Study 2888253 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 193
Study 2888253 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine-Scopolamine (Mo-Scop)
Number of subjects: 193
Study 2888253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study 28887245 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile Fresh Frozen Human Cadaver Circulation Model (PHCM)
Number of subjects: 12
Study 27667332 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal delivery of virosomal vaccine using MicronJet600™
Number of subjects: 370
Study 27667332 — intervention group
Group type: COMPARATOR
Intervention: 45μg dose of virosomal vaccine formulation
Number of subjects: 370
Study 27667332 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 370
Study 25266414 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh gas flow rate of 2 l/min (group D2)
Number of subjects: 105
Study 25266414 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh gas flow rate of 4 l/min (group D4)
Number of subjects: 105
Study 25266414 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh gas flow rate of 6 l/min (group D6)
Number of subjects: 105
Study 22644708 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-loaded HA nanoparticles
Number of subjects: 0
Study 22644708 — intervention group
Group type: COMPARATOR
Intervention: Insulin solution
Number of subjects: 0
Study 20356587 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (M)
Number of subjects: 29
Study 20356587 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (N)
Number of subjects: 29
Study 20356587 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oral contraceptives (OC) and prednisolone (OC/Pr)
Number of subjects: 29
Study 18177922 — intervention group
Group type: EXPERIMENTAL
Intervention: Coxibs
Number of subjects: 0
Study 18177922 — intervention group
Group type: COMPARATOR
Intervention: Traditional NSAIDs
Number of subjects: 0
Study 18177922 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs (including coxibs)
Number of subjects: 0
Study 18177922 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 0
Study 18177922 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose lumiracoxib
Number of subjects: 0
Study 18177922 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumiracoxib
Number of subjects: 0
Study 16484767 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanolic placebo (12 microl 96% ethanol + 0.13 mug EDTA/actuation)
Number of subjects: 37
Study 16484767 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous placebo (12 microl water + 5.5 microg EDTA + 1.1 mug BAC/actuation)
Number of subjects: 37
Study 16484767 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (12 microl 0.9% sodium chloride/actuation)
Number of subjects: 37
Study 16484767 — intervention group
Group type: COMPARATOR
Intervention: Ethanolic placebo vs Normal saline
Number of subjects: 37
Study 16484767 — intervention group
Group type: COMPARATOR
Intervention: Aqueous placebo vs Normal saline
Number of subjects: 37
Study 14584556 — intervention group
Group type: EXPERIMENTAL
Intervention: Left dorsolateral lesions
Number of subjects: 18
Study 14584556 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial lesions
Number of subjects: 18
Study 14584556 — intervention group
Group type: EXPERIMENTAL
Intervention: Right dorsolateral lesions
Number of subjects: 18
Study 14584556 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 18
Study 10925684 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A (CMF: cyclophosphamide 100 mg/body on days 1‐14; methotrexate 40 mg/m2 on days 1 and 8; 5‐fluorouracil 500 mg/m2 on days 1 and 8)
Number of subjects: 44
Study 10925684 — intervention group
Group type: COMPARATOR
Intervention: Regimen B (UFT 300 mg/day and tamoxifen 30 mg/day for 2 years)
Number of subjects: 44
Study 8844884 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy doses ranging from 0.4 to 5.2 Gy per fraction
Number of subjects: 117
Study 8844884 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy doses less than 1.5 Gy per fraction
Number of subjects: 117
Study 8844884 — intervention group
Group type: EXPERIMENTAL
Intervention: Various treatment fractions (5, 10, 12, and 20 daily treatment fractions)
Number of subjects: 117
Study 8844884 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatic irradiation (30-32 fractions)
Number of subjects: 117
Study 1397244 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh platelet concentrates (PC)
Number of subjects: 39
Study 1397244 — intervention group
Group type: COMPARATOR
Intervention: Stored platelet concentrates (PC)
Number of subjects: 39
Study 1397244 — intervention group
Group type: EXPERIMENTAL
Intervention: PC stored 0‐1 d
Number of subjects: 39
Study 1397244 — intervention group
Group type: EXPERIMENTAL
Intervention: PC stored 2‐3 d
Number of subjects: 39
Study 1397244 — intervention group
Group type: EXPERIMENTAL
Intervention: PC stored 4‐5 d
Number of subjects: 39
Study 4029019 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5g temocillin
Number of subjects: 6
Study 4029019 — intervention group
Group type: EXPERIMENTAL
Intervention: 1g temocillin
Number of subjects: 6
Study 4029019 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses (0.5g and 1g)
Number of subjects: 6
Study 29801486 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Bio-Kult® (14 different bacterial strains)
Number of subjects: 400
Study 29801486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 29801486 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Bio-Kult®
Number of subjects: 400
Study 27484227 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-ketamine (DK)
Number of subjects: 56
Study 27484227 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine-midazolam-fentanyl (DMF)
Number of subjects: 56
Study 24444221 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxing music for anxiety control
Number of subjects: 72
Study 24444221 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-relaxing music
Number of subjects: 72
Study 24444221 — intervention group
Group type: COMPARATOR
Intervention: No music control
Number of subjects: 72
Study 22228772 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening with stress myocardial perfusion imaging (MPI)
Number of subjects: 1123
Study 22228772 — intervention group
Group type: COMPARATOR
Intervention: No screening
Number of subjects: 1123
Study 20350033 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Behavioral Couple Therapy (IBCT)
Number of subjects: 134
Study 20350033 — intervention group
Group type: COMPARATOR
Intervention: Traditional Behavioral Couple Therapy (TBCT)
Number of subjects: 134
Study 18509970 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative plateletpheresis combined with intraoperative autotransfusion
Number of subjects: 60
Study 18509970 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative autotransfusion
Number of subjects: 60
Study 18509970 — intervention group
Group type: COMPARATOR
Intervention: No managements of blood conservation
Number of subjects: 60
Study 16210963 — intervention group
Group type: EXPERIMENTAL
Intervention: Alemtuzumab with low-dose cyclosporine (CsA)
Number of subjects: 30
Study 16210963 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (full doses of CsA with azathioprine and corticosteroids)
Number of subjects: 30
Study 12078913 — intervention group
Group type: EXPERIMENTAL
Intervention: Escalated BEACOPP (eight cycles)
Number of subjects: 221
Study 12078913 — intervention group
Group type: EXPERIMENTAL
Intervention: Escalated BEACOPP (four escalated cycles followed by four at baseline dose)
Number of subjects: 221
Study 12078913 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 221
Study 12078913 — intervention group
Group type: COMPARATOR
Intervention: ABVD (eight cycles)
Number of subjects: 221
Study 10422019 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid plus Rifampicin (HR) for 6 or 9 months with radical surgical resection and bone grafting, plus Streptomycin for 6 months (Hong Kong)
Number of subjects: 0
Study 10422019 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid plus Rifampicin (HR) for 6 or 9 months (Madras)
Number of subjects: 0
Study 10422019 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid plus Ethambutol (EH) for 9 or 18 months or Isoniazid plus PAS (PH) (Korea)
Number of subjects: 0
Study 7545380 — intervention group
Group type: EXPERIMENTAL
Intervention: DDAVP infusion (group I)
Number of subjects: 23
Study 7545380 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (group II)
Number of subjects: 23
Study 2209496 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine (Group A)
Number of subjects: 64
Study 2209496 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine plus thrombin (Group B)
Number of subjects: 64
Study 2209496 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine (Group A) and Epinephrine plus thrombin (Group B)
Number of subjects: 64
Study 2209496 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-injected patients after second endoscopy
Number of subjects: 64
Study 7237899 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 17
Study 7237899 — intervention group
Group type: COMPARATOR
Intervention: Methyldopa
Number of subjects: 17
Study 31941834 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 422
Study 31941834 — intervention group
Group type: COMPARATOR
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 422
Study 30353743 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide (20 μg, 8 weeks)
Number of subjects: 35
Study 30353743 — intervention group
Group type: COMPARATOR
Intervention: Insulin glulisine (titrated once-daily)
Number of subjects: 35
Study 29151458 — intervention group
Group type: EXPERIMENTAL
Intervention: Home bleaching (HB)
Number of subjects: 40
Study 29151458 — intervention group
Group type: COMPARATOR
Intervention: In-office bleaching (OB)
Number of subjects: 40
Study 25641260 — intervention group
Group type: EXPERIMENTAL
Intervention: Gla‐300
Number of subjects: 878
Study 23795871 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance use treatment (Brief Strategic Family Therapy)
Number of subjects: 480
Study 20645126 — intervention group
Group type: EXPERIMENTAL
Intervention: Control over the initial contingent negative variation (iCNV)
Number of subjects: 24
Study 20645126 — intervention group
Group type: EXPERIMENTAL
Intervention: Control over the terminal contingent negative variation (tCNV)
Number of subjects: 24
Study 18819961 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aspirin (>/=200 mg)
Number of subjects: 2658
Study 18819961 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-dose aspirin (101-199 mg)
Number of subjects: 2658
Study 18819961 — intervention group
Group type: COMPARATOR
Intervention: Low-dose aspirin (</=100 mg)
Number of subjects: 2658
Study 18819961 — intervention group
Group type: COMPARATOR
Intervention: High-dose aspirin (>/=200 mg) vs Low-dose aspirin (</=100 mg)
Number of subjects: 2658
Study 17377079 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan 0.1 microg [corrected] x kg(‐1) x min(‐1)
Number of subjects: 30
Study 17377079 — intervention group
Group type: COMPARATOR
Intervention: Milrinone 0.5 microg [corrected] x kg(‐1) x min(‐1)
Number of subjects: 30
Study 14994265 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding
Number of subjects: 0
Study 14994265 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention to visual stimuli
Number of subjects: 0
Study 11371485 — intervention group
Group type: COMPARATOR
Intervention: Granisetron 40 microg/kg
Number of subjects: 80
Study 11371485 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 6 microg/kg
Number of subjects: 80
Study 9702614 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 60
Study 9702614 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% albumin
Number of subjects: 60
Study 9702614 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch
Number of subjects: 60
Study 9702614 — intervention group
Group type: EXPERIMENTAL
Intervention: All three diluents
Number of subjects: 60
Study 7977774 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% amino acid solution infused at 0.5 ml.kg‐1.min‐1 (group I)
Number of subjects: 8
Study 7977774 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% amino acid solution infused at 1.0 ml.kg‐1.min‐1 (group II)
Number of subjects: 8
Study 7977774 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% amino acid solution infused at 2.0 ml.kg‐1.min‐1 (group III)
Number of subjects: 8
Study 7977774 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% amino acid solution infused at 4.0 ml.kg‐1.min‐1 (group IV)
Number of subjects: 8
Study 7977774 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% amino acid solution infused at 6.0 ml.kg‐1.min‐1 (group V)
Number of subjects: 8
Study 2466449 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% pentastarch
Number of subjects: 0
Study 2466449 — intervention group
Group type: COMPARATOR
Intervention: 5% albumin
Number of subjects: 0
Study 31868684 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa (regular dose)
Number of subjects: 37
Study 30536129 — intervention group
Group type: EXPERIMENTAL
Intervention: nCRT
Number of subjects: 220
Study 30536129 — intervention group
Group type: COMPARATOR
Intervention: nCT
Number of subjects: 220
Study 26750388 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week Cognitive Behavioural Therapy-based group treatment for hoarding disorder
Number of subjects: 77
Study 25807028 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased bar velocity group (IVG)
Number of subjects: 24
Study 25807028 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced bar velocity group (RVG)
Number of subjects: 24
Study 25807028 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 24
Study 23553154 — intervention group
Group type: EXPERIMENTAL
Intervention: Powdered black tea solids (3 cups/d)
Number of subjects: 111
Study 23553154 — intervention group
Group type: COMPARATOR
Intervention: Flavonoid‐free caffeine‐matched beverage (control)
Number of subjects: 111
Study 21789385 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil at 1.5 ng/mL (group I)
Number of subjects: 69
Study 21789385 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil at 2 ng/mL (group II)
Number of subjects: 69
Study 21789385 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil at 2.5 ng/mL (group III)
Number of subjects: 69
Study 19855343 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (PT)
Number of subjects: 22
Study 19855343 — intervention group
Group type: COMPARATOR
Intervention: Habitual training (HT)
Number of subjects: 22
Study 16954359 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-polyphenol olive oil (2.7 mg/kg)
Number of subjects: 200
Study 16954359 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-polyphenol olive oil (164 mg/kg)
Number of subjects: 200
Study 16954359 — intervention group
Group type: EXPERIMENTAL
Intervention: High-polyphenol olive oil (366 mg/kg)
Number of subjects: 200
Study 16954359 — intervention group
Group type: EXPERIMENTAL
Intervention: All olive oils
Number of subjects: 200
Study 19667682 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational brochure
Number of subjects: 6922
Study 19667682 — intervention group
Group type: COMPARATOR
Intervention: No educational brochure (Control)
Number of subjects: 6922
Study 11361046 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release (CR) oxycodone q12h
Number of subjects: 30
Study 11361046 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release (IR) oxycodone qid
Number of subjects: 30
Study 9429915 — intervention group
Group type: EXPERIMENTAL
Intervention: Binge Eating Scale (BES)
Number of subjects: 128